- All sections
- C - Chemistrymetallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/06 - Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Patent holdings for IPC class C12P 21/06
Total number of patents in this class: 2175
10-year publication summary
|
107
|
89
|
96
|
81
|
85
|
96
|
83
|
76
|
82
|
66
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4873 |
46 |
| The Regents of the University of California | 20960 |
41 |
| Novozymes A/S | 3406 |
40 |
| DSM IP Assets B.V. | 5395 |
24 |
| Danisco US Inc. | 1147 |
22 |
| Codexis, Inc. | 812 |
19 |
| Massachusetts Institute of Technology | 10322 |
17 |
| Amano Enzyme Inc. | 467 |
17 |
| The Scripps Research Institute | 1345 |
17 |
| Novozymes, Inc. | 276 |
16 |
| The Board of Trustees of the Leland Stanford Junior University | 6724 |
15 |
| Gevo, Inc. | 286 |
15 |
| Amgen Inc. | 4483 |
11 |
| Merck Sharp & Dohme LLC | 3734 |
11 |
| President and Fellows of Harvard College | 6118 |
10 |
| CJ Cheiljedang Corporation | 3706 |
10 |
| Janssen Biotech, Inc. | 1798 |
10 |
| Momenta Pharmaceuticals, Inc. | 298 |
10 |
| Novartis AG | 10170 |
9 |
| Hoffmann-La Roche Inc. | 3864 |
9 |
| Other owners | 1806 |